Diagnostic Tool Development Suppliers Serving Egypt

Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...

Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and committed to providing ...

At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...

Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has developed instruments for molecular diagnostics based on OEM partnership. In addition to that, Seegene has developed its own ...

NOVO has been providing engineering services to medtech, biotech, print-tech, and other technical product companies for the last two decades. We are a company purpose built for developing new products and solving complex hardware and software ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...

Vitassay develops and distributes reliable and certified solutions for the early detection of different pathogens which cause infectious diseases in humans. Our greatest asset is to offer a complete service for every customer to exceed their ...

MiraVista Veterinary Diagnostics is the veterinary division of MiraVista Diagnostics, a specialty laboratory in Indianapolis, Indiana devoted to detection and monitoring of systemic fungal infections. The company was founded in 2002 by the renowned ...

Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...

Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...

S-Matrix develops advanced and innovative Quality by Design software. S-Matrix has changed our product name from Fusion AE to Fusion QbD® as an acknowledgement of our commitment to developing software that is 100% aligned with Quality by Design ...

Aikang MedTech Co., Ltd. was founded in 2003, is a high-tech enterprise specializing in medical equipment and in vitro diagnostic reagents product, integrating production, sales and after-sales service. Aikang has four platforms of ELISA analyzer, ...

AgPlus Diagnostics is proud to present the Agilis Reader. A portable diagnostic solution, comparable to any fixed laboratory analyzer, The Agilis Reader is a quantitative diagnostic reader that can be used in multiple market applications that when ...

We are a global biomedical technology company that offers advanced in-vitro diagnostic solutions. We develop, patent, manufacture and market IVD products. Our primary research and development focus is on gastrointestinal and inflammatory diseases ...

DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services, including clinical trials and regulatory services, specializing in the development of custom assays, consumables, and instruments for point-of-use applications. ...

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...

Nexstim was established in 2000 to commercialise the opportunity of adding navigation to an existing transcranial magnetic stimulation (TMS) technology. The founders believed that navigation and making the TMS visible with the help of navigation is ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by ...

Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...